Scleroderma, Systemic Completed Phase 2 / 3 Trials for Bosentan (DB00559)

Also known as: Systemic Scleroderma

IndicationStatusPhase
DBCOND0028174 (Scleroderma, Systemic)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070590Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaTreatment